BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28935469)

  • 21. The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses.
    Tokars JI; Lewis P; DeStefano F; Wise M; Viray M; Morgan O; Gargiullo P; Vellozzi C
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):546-52. PubMed ID: 22407672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of the risk of autoimmune thyroiditis, Guillain-Barré syndrome, and inflammatory bowel disease following vaccination with AS04-adjuvanted human papillomavirus 16/18 vaccine.
    Rosillon D; Willame C; Tavares Da Silva F; Guignard A; Caterina S; Welby S; Struyf F
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1159-1167. PubMed ID: 32583515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series.
    Crawford NW; Cheng A; Andrews N; Charles PG; Clothier HJ; Day B; Day T; Gates P; Macdonell R; Roberts L; Rodriguez-Casero V; Wijeratne T; Kiers L
    Med J Aust; 2012 Nov; 197(10):574-8. PubMed ID: 23163689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination.
    Velentgas P; Amato AA; Bohn RL; Chan KA; Cochrane T; Funch DP; Dashevsky I; Duddy AL; Gladowski P; Greenberg SA; Kramer JM; McMahill-Walraven C; Nakasato C; Spettell CM; Syat BL; Wahl PM; Walker AM; Zhang F; Brown JS; Platt R
    Pharmacoepidemiol Drug Saf; 2012 Dec; 21(12):1350-8. PubMed ID: 22807266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink.
    Gee J; Naleway A; Shui I; Baggs J; Yin R; Li R; Kulldorff M; Lewis E; Fireman B; Daley MF; Klein NP; Weintraub ES
    Vaccine; 2011 Oct; 29(46):8279-84. PubMed ID: 21907257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus vaccination and risk of autoimmune diseases: A large cohort study of over 2million young girls in France.
    Miranda S; Chaignot C; Collin C; Dray-Spira R; Weill A; Zureik M
    Vaccine; 2017 Aug; 35(36):4761-4768. PubMed ID: 28750853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postlicensure safety surveillance of congenital anomaly and miscarriage among pregnancies exposed to quadrivalent human papillomavirus vaccine.
    Sy LS; Meyer KI; Klein NP; Chao C; Velicer C; Cheetham TC; Ackerson BK; Slezak JM; Takhar HS; Hansen J; Deosaransingh K; Liaw KL; Jacobsen SJ
    Hum Vaccin Immunother; 2018 Feb; 14(2):412-419. PubMed ID: 29140750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec.
    De Wals P; Deceuninck G; Toth E; Boulianne N; Brunet D; Boucher RM; Landry M; De Serres G
    JAMA; 2012 Jul; 308(2):175-81. PubMed ID: 22782419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza vaccination and Guillain Barre syndrome.
    Geier MR; Geier DA; Zahalsky AC
    Clin Immunol; 2003 May; 107(2):116-21. PubMed ID: 12763480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database.
    Alcalde-Cabero E; Almazán-Isla J; García López FJ; Ara-Callizo JR; Avellanal F; Casasnovas C; Cemillán C; Cuadrado JI; Duarte J; Fernández-Pérez MD; Fernández Ó; Merino JA; Montero RG; Montero D; Pardo J; Rodríguez-Rivera FJ; Ruiz-Tovar M; de Pedro-Cuesta J;
    BMC Neurol; 2016 May; 16():75. PubMed ID: 27206524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population-Based Incidence of Guillain-Barré Syndrome During Mass Immunization With Viral Vaccines: A Pooled Analysis.
    Wang F; Wang D; Wang Y; Li C; Zheng Y; Guo Z; Liu P; Zhang Y; Wang W; Wang Y; Hou H
    Front Immunol; 2022; 13():782198. PubMed ID: 35185881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Near real-time surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2010/11 to 2013/14.
    Sandhu SK; Hua W; MaCurdy TE; Franks RL; Avagyan A; Kelman J; Worrall CM; Ball R; Nguyen M
    Vaccine; 2017 May; 35(22):2986-2992. PubMed ID: 28449973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guillain-Barré syndrome following influenza vaccination.
    Haber P; DeStefano F; Angulo FJ; Iskander J; Shadomy SV; Weintraub E; Chen RT
    JAMA; 2004 Nov; 292(20):2478-81. PubMed ID: 15562126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incident autoimmune conditions among males receiving quadrivalent human papillomavirus vaccine in the United States.
    Seeger JD; Amend KL; Turnbull BR; Zhou L; Marks MA; Velicer C; Saddier P
    Vaccine; 2023 Mar; 41(11):1826-1833. PubMed ID: 36424257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal and infant outcomes following exposure to quadrivalent human papillomavirus vaccine during pregnancy.
    Bukowinski AT; Hall C; Chang RN; Gumbs GR; Marie S Conlin A
    Vaccine; 2020 Aug; 38(37):5933-5939. PubMed ID: 32712082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended surveillance to assess safety of 9-valent human papillomavirus vaccine.
    Sundaram ME; Kieke BA; Hanson KE; Belongia EA; Weintraub ES; Daley MF; Hechter RC; Klein NP; Lewis EM; Naleway AL; Nelson JC; Donahue JG
    Hum Vaccin Immunother; 2022 Dec; 18(7):2159215. PubMed ID: 36577134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, October 2005-February 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Apr; 55(13):364-6. PubMed ID: 16601664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine-preventable diseases, vaccines and Guillain-Barre' syndrome.
    Principi N; Esposito S
    Vaccine; 2019 Sep; 37(37):5544-5550. PubMed ID: 29880241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
    Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N;
    Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.